ANC after G-CSF administration in different CN groups
| CN group . | G-CSF responsiveness . | Total cases (n) . | |||
|---|---|---|---|---|---|
| pANC ≥3.0 . | 1.5 ≤ pANC<3.0 . | 1.0 ≤ pANC<1.5 . | pANC<1.0 . | ||
| SCN1 n (%) | 3 (12%) | 10 (40%) | 6 (24%) | 6 (24%) | 25 |
| SCN3 n (%) | 0 (0%) | 2 (50%) | 1 (50%) | 1 (50%) | 4 |
| CyN n (%) | 2 (100%) | 0 (0%) | 0 (0%) | 0 (0%) | 2 |
| WHIM n (%) | 3 (75%) | 0 (0%) | 1 (50%) | 0 (0%) | 4 |
| SBDS n (%) | 2 (50%) | 1 (25%) | 1 (25%) | 0 (0%) | 4 |
| CN group . | G-CSF responsiveness . | Total cases (n) . | |||
|---|---|---|---|---|---|
| pANC ≥3.0 . | 1.5 ≤ pANC<3.0 . | 1.0 ≤ pANC<1.5 . | pANC<1.0 . | ||
| SCN1 n (%) | 3 (12%) | 10 (40%) | 6 (24%) | 6 (24%) | 25 |
| SCN3 n (%) | 0 (0%) | 2 (50%) | 1 (50%) | 1 (50%) | 4 |
| CyN n (%) | 2 (100%) | 0 (0%) | 0 (0%) | 0 (0%) | 2 |
| WHIM n (%) | 3 (75%) | 0 (0%) | 1 (50%) | 0 (0%) | 4 |
| SBDS n (%) | 2 (50%) | 1 (25%) | 1 (25%) | 0 (0%) | 4 |
pANC, peak ANC (×109 cells per L) within 10 days after G-CSF initiation.